Triple
T20723202
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Air Test and Evaluation Squadron 9 |
E509369
|
entity |
| Predicate | abbreviation |
P43
|
FINISHED |
| Object |
VX-9
VX-9 is a U.S. Navy air test and evaluation squadron responsible for operational testing of strike and fighter aircraft and their weapons systems.
|
E1447203
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: VX-9 | Statement: [Air Test and Evaluation Squadron 9, abbreviation, VX-9]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: VX-9 Context triple: [Air Test and Evaluation Squadron 9, abbreviation, VX-9]
-
A.
VX-8
VX-8 is a U.S. Navy air test and evaluation squadron responsible for testing, evaluating, and integrating advanced aviation systems and weapons.
-
B.
VX-4
VX-4 was a U.S. Navy air test and evaluation squadron known for operational testing of fighter aircraft and weapons systems.
-
C.
VX-1
VX-1 is a U.S. Navy air test and evaluation squadron responsible for operational testing of maritime patrol, reconnaissance, and other naval aviation systems.
-
D.
VX-3
VX-3 was a U.S. Navy Air Test and Evaluation Squadron responsible for testing and evaluating naval aircraft, weapons, and related systems.
-
E.
VX-880
VX-880 is an investigational cell-based therapy being developed by Vertex Pharmaceuticals for the treatment of type 1 diabetes by replacing lost insulin-producing beta cells.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: VX-9 Triple: [Air Test and Evaluation Squadron 9, abbreviation, VX-9]
Generated description
VX-9 is a U.S. Navy air test and evaluation squadron responsible for operational testing of strike and fighter aircraft and their weapons systems.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: VX-9 Target entity description: VX-9 is a U.S. Navy air test and evaluation squadron responsible for operational testing of strike and fighter aircraft and their weapons systems.
-
A.
VX-8
VX-8 is a U.S. Navy air test and evaluation squadron responsible for testing, evaluating, and integrating advanced aviation systems and weapons.
-
B.
VX-4
VX-4 was a U.S. Navy air test and evaluation squadron known for operational testing of fighter aircraft and weapons systems.
-
C.
VX-1
VX-1 is a U.S. Navy air test and evaluation squadron responsible for operational testing of maritime patrol, reconnaissance, and other naval aviation systems.
-
D.
VX-3
VX-3 was a U.S. Navy Air Test and Evaluation Squadron responsible for testing and evaluating naval aircraft, weapons, and related systems.
-
E.
VX-880
VX-880 is an investigational cell-based therapy being developed by Vertex Pharmaceuticals for the treatment of type 1 diabetes by replacing lost insulin-producing beta cells.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e0b4c4cc648190b45fda6e2b20af56 |
completed | April 16, 2026, 10:07 a.m. |
| NER | Named-entity recognition | batch_69e6c1e59b2081909fb6c29cb5018bb4 |
completed | April 21, 2026, 12:16 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_6a08e0595d408190b9a8c2b063a83b5d |
completed | May 16, 2026, 9:23 p.m. |
| NEDg | Description generation | batch_6a08e12d0d8c81909527575f628ec2d2 |
completed | May 16, 2026, 9:27 p.m. |
| NED2 | Entity disambiguation (via description) | batch_6a08e1a7f16c8190af9a1dde4263e21d |
completed | May 16, 2026, 9:29 p.m. |
Created at: April 16, 2026, 12:28 p.m.